171 related articles for article (PubMed ID: 97039)
1. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
Palosuo T; Kajander A; von Essen R; Milgrom F
Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039
[No Abstract] [Full Text] [Related]
2. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
[TBL] [Abstract][Full Text] [Related]
3. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
[No Abstract] [Full Text] [Related]
4. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Dahlqvist SR; Ström H; Bjelle A; Möller E
Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
[TBL] [Abstract][Full Text] [Related]
5. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
[TBL] [Abstract][Full Text] [Related]
6. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
[TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to D-penicillamine after gold toxicity.
Dodd MJ; Griffiths ID; Thompson M
Br Med J; 1980 Jun; 280(6230):1498-500. PubMed ID: 6770953
[TBL] [Abstract][Full Text] [Related]
8. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
Farr M; Kitas G; Bacon PA
Clin Rheumatol; 1988 Jun; 7(2):242-8. PubMed ID: 2901303
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
10. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
Bird HA
Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
[No Abstract] [Full Text] [Related]
11. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
[TBL] [Abstract][Full Text] [Related]
12. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
Munthe E; Kåss E
J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
[TBL] [Abstract][Full Text] [Related]
14. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
Haataja M; Nissilä M; Ruutsalo HM
Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
[TBL] [Abstract][Full Text] [Related]
15. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
Jellum E; Aaseth J; Munthe E
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
[No Abstract] [Full Text] [Related]
16. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
Redda A; Anastassiades T
Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
[TBL] [Abstract][Full Text] [Related]
17. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
[No Abstract] [Full Text] [Related]
18. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
Leonard PA; Bienz SR; Clegg DO; Ward JR
J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
[TBL] [Abstract][Full Text] [Related]
19. Gold vs D-penicillamine double blind study and followup.
Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
[TBL] [Abstract][Full Text] [Related]
20. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
Grindulis KA; McConkey B
Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
